Citation Impact
Citing Papers
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
1991 Standout
Binding of heparin and heparan sulphate to rat liver cells
1977
Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins
1989
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1994 Standout
Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat
1990
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
1990 Standout
Beyond Cholesterol
1989 Standout
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 Standout
Ghrelin Stimulates Gastric Acid Secretion and Motility in Rats
2000
Vincristine revisited
1999
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
1999
Clinical Applications of Research on Angiogenesis
1995 Standout
How were new medicines discovered?
2011 Standout
Type 1 diabetes
2013 Standout
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response.
1995 StandoutNobel
Microtubules as a target for anticancer drugs
2004 Standout
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 Standout
Glycoconjugates in normal human kidney
1988
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
2001 Standout
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
2002 Standout
Alzheimer's Disease
2004 Standout
Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer
1994
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Ghrelin: Structure and Function
2005 Standout
Role of oxidized low density lipoprotein in atherogenesis.
1991 Standout
In Situ Click Chemistry: Enzyme‐Generated Inhibitors of Carbonic Anhydrase II
2004 StandoutNobel
Insulin Pharmacology
1988
Ir-gene control of immunogenicity of insulin and A-chain loop as a carrier determinant
1975 Nature
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
1986 Standout
Overexpression of beta 2-microglobulin in transgenic mouse islet beta cells results in defective insulin secretion.
1991 StandoutNobel
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Chemotherapy of brain metastases: Current status
1984
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MAN
1960 StandoutNobel
Atherosclerosis: Basic Mechanisms
1995 Standout
Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells
1985
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
1981
Phosphine Organocatalysis
2018 Standout
Synthesis of trinorbornane
2017 StandoutNobel
The preparation of deslysylalanyl porcine and bovine insulins
1975
A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway.
1988
Understanding Adipocyte Differentiation
1998 Standout
CLINICAL AND EXPERIMENTAL STUDIES OF INSULIN SECRETION FOLLOWING TOLBUTAMIDE AND METAHEXAMIDE ADMINISTRATION
1959
Tissue lipoprotein lipase activity and its action in lipoprotein metabolism
1981
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels
1982 Standout
Chemical studies of caged compounds. II the synthesis of pentacyclo [6,3,0,02,6,03,10,05,9] undecane: trishomocubane
1970
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Hypoglycaemic agents: variants of tolbutamide
1964
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Angiogenic Factors
1987 StandoutScience
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
1984 Science
A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture
1980
Isolation and structure of urogastrone and its relationship to epidermal growth factor
1975 StandoutNature
Preferential distribution of anionic sites on the basement membrane and the abluminal aspect of the endothelium in fenestrated capillaries.
1982 Nobel
Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses.
1976 StandoutNobel
Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors.
1985
Imaging the glycome
2008 StandoutNobel
Isolation and functional expression of a mammalian prohormone processing enzyme, murine prohormone convertase 1.
1991 StandoutNobel
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Cell biology of endothelial cells
1987
Models for the Specific Adhesion of Cells to Cells
1978 StandoutScience
Anticoagulantly active heparin-like molecules from vascular tissue
1984
Prospective Study of the Association Between the Proline to Alanine Codon 12 Polymorphism in the PPARγ Gene and Type 2 Diabetes
2003
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Phosphine-catalyzed [3 + 2] cycloaddition of ethyl buta-2,3-dienoate to adamantane-containing N-substituted maleimides
2017
Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
1981
Natural anticoagulant mechanisms.
1984
The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains
1984 StandoutNatureNobel
Secretion and processing of insulin precursors in yeast.
1986
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Interleukin-8 as a Macrophage-Derived Mediator of Angiogenesis
1992 StandoutScience
Immune Endothelial-Cell Injury in Heparin-Associated Thrombocytopenia
1987
The pathogenesis of atherosclerosis.
1973
Type I Diabetes Mellitus
1986
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
Angiogenesis.
1992 Standout
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of Mary A. Root being referenced
Pharmacokinetics of vindesine and vincristine in humans.
1977
Enzymatic degradation of heparin-related mucopolysaccharides from the surface of endothelial cell cultures
1975
A radioimmunoassay for circulating human proinsulin
1985
Metabolic Reduction of 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea (Acetohexamide) in Different Species
1961
The Adamantyl Group in Medicinal Agents. I. Hypoglycemic N-Arylsulfonyl-N'-adamantylureas
1963
Lipase, esterase and triglyceride in the ageing human aorta
1969
The immunogenicity of insulin preparations.
1976
Effect of Garbutamide on the Insulin Content of the Dog Pancreas
1957
Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia
1986
A Radioimmunoassay for Circulating Human Proinsulin
1985
Human proinsulin standards
1984
Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer
1980
Action of somatostatin on stomach, pancreas, gastric mucosal blood flow, and hormones
1983
Immunogenicity of Insulin
1972